A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new ...
Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
News-Medical.Net on MSN
New trial aims to improve both survival and quality of life for men with advanced prostate cancer
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
A randomized trial from Vanderbilt-Ingram Cancer Center reveals that magnesium may be the missing key to keeping vitamin D ...
MedPage Today on MSN
Opportunistic Cholesterol Gene Screens: Good in Theory Only?
The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...
Clinical Trials Arena on MSN
Ascletis receives FDA approval for diabetes mellitus clinical trial of ASC30
Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...
A NIMHANS study reveals yoga can significantly reduce opioid withdrawal time, enhancing recovery alongside standard medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback